Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis
The Oncologist · 01.09.2025 · 30 (9)
DOI: 10.1093/oncolo/oyaf254 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Oncologist, online erschienen am 21.08.2025. Verfasst von Francesca Zacchi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and University and Hospital …. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Interleukin-8, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bando Interno Ricerca Corrente, Ricerca Corrente, Italian Ministry of Health.
Abstract (Originalsprache)
Background and Objective Interleukin-8 (IL-8) is a chemokine involved in inflammation and primary immune response, playing a key role in recruiting neutrophils. IL-8 is produced by several cell types, including immune cells and certain cancer cells. Elevated levels of IL-8 have been associated with a poorer outcome in several tumors and have been related to advanced diseases, treatment resistance, and possibly promoting neo angiogenesis and immune cell recruitment. In the renal cell carcinoma (RCC), the prognostic role of IL-8 has not been settled.
Methods
From January 1, 2008 to June 18, 2024, PubMed, Embase, and Scopus databases were searched for all studies investigating the potential prognostic role of IL-8 in RCC. All studies were rated according to the Newcastle-Ottawa Scale. Progression-free survival (PFS) and overall survival (OS) were analyzed as clinical outcomes, and a meta-analysis was performed for both. Key Findings and Limitations Overall, six papers met the predefined inclusion criteria, with final analyses demonstrating that high IL-8 levels significantly correlate with worse prognosis in RCC, with a statistically shorter PFS (hazard ratio [HR]: 1.27, 95% confidence interval [CI]: 1.01-1.59; P = 0.037) and statistically shorter OS (HR: 1.85, 95% CI: 1.21-2.84; P = .001). Prospective randomized clinical trials are also necessary to investigate the predictive role of IL-8 in the contemporary treatment scenario of RCC to improve clinical decision-making.
Conclusions
This meta-analysis demonstrates the significant prognostic role of IL-8 in RCC, suggesting that IL-8 could be used to refine the prognostic RCC assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona 37134, Italy.
- Centro Ricerche Cliniche, Azienda Ospedaliera Integrata, Verona 37134, Italy.
- Oncology Department, San Maurizio Central Hospital of Bolzano, South Tyrolean Health Service, Bolzano 39100, Italy.
- Oncology Unit 1, Istituto Oncologico Veneto, IOV-IRCCS, Padova 35128, Italy.
- Department of Oncology, Ospedale Pederzoli, Verona 37019, Italy.
- Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona 37134, Italy.
ORCID-Profile: Francesca Zacchi, Michele Milella
Förderung
- Bando Interno Ricerca Corrente
- Ricerca Corrente
- Italian Ministry of Health
Zitieren
APA
Zacchi, F., Merler, S., Zampiva, I., Torresan, I., Manduca, S., Piacentini, M., Lorenzi, C., Fantinel, E., Pafumi, S., Inzerilli, N., Caliò, A., Brunelli, M., Veccia, A., Antonelli, A., Tondulli, L., Conciatori, F., Bazzichetto, C., Verlato, G., Torroni, L., & Milella, M. (2025). Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis. The Oncologist, 30(9). https://doi.org/10.1093/oncolo/oyaf254
Vancouver
Zacchi F, Merler S, Zampiva I, Torresan I, Manduca S, Piacentini M, et al. Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis. The Oncologist. 2025;30(9). doi:10.1093/oncolo/oyaf254
BibTeX
@article{Zacchi2025,
author = {Zacchi, Francesca and Merler, Sara and Zampiva, Ilaria and Torresan, Irene and Manduca, Stefano and Piacentini, Michela and Lorenzi, Clara and Fantinel, Emanuela and Pafumi, Sarah and Inzerilli, Nicola and Caliò, Anna and Brunelli, Matteo and Veccia, Alessandro and Antonelli, Alessandro and Tondulli, Luca and Conciatori, Fabiana and Bazzichetto, Chiara and Verlato, Giuseppe and Torroni, Lorena and Milella, Michele},
title = {Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis},
journal = {The Oncologist},
year = {2025},
volume = {30},
number = {9},
doi = {10.1093/oncolo/oyaf254}
}
EUVIMED